Kimberly Jo Tzoumakas
Director at Oncology Institute, Inc. (STLN) since February 2026
Kimberly Jo Tzoumakas has filed 7 insider reports with the SEC since January 2022, as director at Oncology Institute, Inc. (STLN) and director at Coherus BioSciences, Inc. (CHRS). The latest filing, on July 29, 2026, reports grant or award at Oncology Institute, Inc. (STLN).
- Filings
- 7
- Companies
- 2
- Bought on market
- None
- Sold on market
- None
Companies where Kimberly Jo Tzoumakas is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Directorsince February 2026 | 46,301 | $3.20 | Jul 29, 2026 | ||||
| Director | $0.4099 | Jun 5, 2024 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jul 27, 2026STLNDirector Tzoumakas Kimberly Jo was granted 29,116 shares, increasing direct ownership by 169% to 46,301 unitsForm 4Grant or award
- Jul 7, 2026STLNDirector Tzoumakas Kimberly Jo was granted 17,185 sharesForm 4Grant or award
- Feb 23, 2026STLNKimberly Jo Tzoumakas became an insiderForm 3New insider
- Jun 3, 2024CHRSSEC Form 4 filed by Tzoumakas Kimberly JoForm 4Grant or award
- Jun 7, 2023CHRSSEC Form 4 filed by Tzoumakas Kimberly JoForm 4Grant or award
- Jan 7, 2022CHRSSEC Form 4 filed by Tzoumakas Kimberly Jo (Amendment)Form 4Grant or award
- Jan 7, 2022CHRSSEC Form 4 filed by Tzoumakas Kimberly JoForm 4Grant or award
Also sits on boards with
Officers and directors who share two or more companies with Kimberly Jo Tzoumakas.
Compare Kimberly Jo Tzoumakas with
- Kimberly Jo Tzoumakas vs Mark Stolper2 shared
- Kimberly Jo Tzoumakas vs Yale Podnos1 shared
- Kimberly Jo Tzoumakas vs Jorey Chernett1 shared
- Kimberly Jo Tzoumakas vs Brad Hively1 shared
- Kimberly Jo Tzoumakas vs Mohit Kaushal1 shared
- Kimberly Jo Tzoumakas vs Anne McGeorge1 shared
Other insiders at the same companies
- Yale PodnosSTLN
- Jorey ChernettSTLN
- Brad HivelySTLN
- Mohit KaushalSTLN
- Anne McGeorgeSTLN
- Mark L PacalaSTLN
- Karen Marie JohnsonSTLN
- Ali J. SatvatCHRS
- Rita A KarachunCHRS
- Lee Nisley NewcomerCHRS
- Michael Lee RyanCHRS
- Jill O'Donnell-TormeyCHRS
- Mats WahlstromCHRS
- Charles W. NewtonCHRS
- Bryan J McMichaelCHRS
Questions about Kimberly Jo Tzoumakas
- What is Kimberly Jo Tzoumakas's role at Oncology Institute, Inc.?
- Kimberly Jo Tzoumakas reports to the SEC as director at Oncology Institute, Inc. (STLN), according to the latest filing on July 29, 2026. Kimberly Jo Tzoumakas has also filed as director at Coherus BioSciences, Inc. (CHRS).
- How many shares does Kimberly Jo Tzoumakas own?
- After the latest filing that states it, Kimberly Jo Tzoumakas directly owned 46,301 shares of Oncology Institute, Inc. (STLN). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Kimberly Jo Tzoumakas bought or sold stock recently?
- No open-market purchases or sales by Kimberly Jo Tzoumakas are on file. The filings report grant or award.
- How do I get alerts when Kimberly Jo Tzoumakas files?
- Follow Kimberly Jo Tzoumakas on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Kimberly Jo Tzoumakas (SEC CIK 0001766666). Totals count each trade once, skipping amendments whose original is on file, from Jan 10, 2022 on. View on SEC EDGAR